Role of neuro-immunological factors in the pathophysiology of mood disorders

@article{Bhattacharya2016RoleON,
  title={Role of neuro-immunological factors in the pathophysiology of mood disorders},
  author={Anindya Bhattacharya and No{\"e}l C. Derecki and Timothy W. Lovenberg and Wayne C. Drevets},
  journal={Psychopharmacology},
  year={2016},
  volume={233},
  pages={1623-1636}
}
Mood disorders, despite the widespread availability of monoamine-based antidepressant treatments, are associated with persistently high rates of disability, together with elevated rates of mortality due to suicide, cardiovascular disease, and other causes. The development of more effective treatments has been hindered by the lack of knowledge about the etiology and pathogenesis of mood disorders. An emerging area of science that promises novel pathways to antidepressant and mood stabilizing… 
Role of Neuro-Immunological Factors in the Pathophysiology of Mood Disorders: Implications for Novel Therapeutics for Treatment Resistant Depression.
TLDR
Evidence that the compounds that reduce the release or signaling of neuroactive cytokines, particularly IL-1β, IL-6, and TNF-α, can exert antidepressant effects in subgroups of depressed patients who are identified by blood-based biomarkers associated with inflammation is reviewed.
Immune-based strategies for mood disorders: facts and challenges
TLDR
The evidence showing low-grade inflammation in mood disorders and the studies evaluating immune-based strategies for the treatment of these conditions are reviewed.
ATP-activated P2X7 receptor in the pathophysiology of mood disorders and as an emerging target for the development of novel antidepressant therapeutics
TLDR
Recent progress in understanding the role of the P2X7 receptor in the pathogenesis and development of mood disorders and in discovering CNS-penetrable P2x7 antagonists for potential uses in in vivo imaging to monitor brain inflammation and antidepressant therapeutics are discussed.
Biological hypotheses and biomarkers of bipolar disorder
TLDR
Current biological hypotheses of BD are summarized, including related pathophysiological processes and key biomarkers, which have been associated with changes in genetics, systems of neurotransmitter and neurotrophic factors, neuroinflammation, autoimmunity, cytokines, stress axis activity, chronobiology, oxidative stress, and mitochondrial dysfunctions.
The role of adenosine receptors in mood and anxiety disorders
TLDR
The results discussed here indicate that the adenosinergic system is involved in both the etiology and the treatment of mood and anxiety disorders.
Is There a Future for PPARs in the Treatment of Neuropsychiatric Disorders?
TLDR
Running findings in support of a role for PPARs in the treatment of neurological diseases, including Alzheimer’s disease or psychiatric disorders, such as major depression are reviewed.
Neuroprotective roles of neurotrophic factors in depression
TLDR
This chapter will provide a concise overview of impaired neurotrophic factor signaling in depression and comment on how impaired neuroprotection may contribute to depressive disorders in neurodegenerative diseases.
Pro-inflammatory monocyte profile in patients with major depressive disorder and suicide behaviour and how ketamine induces anti-inflammatory M2 macrophages by NMDAR and mTOR
TLDR
The results suggest an anti-inflammatory property of ketamine that can skew macrophages to an M2-like phenotype, highlighting potential therapeutic implications not only for patients with MDD but also other inflammatory-based diseases.
Potential of Glial Cell Modulators in the Management of Substance Use Disorders
TLDR
The paper reviews the pre-clinical and clinical studies assessing the effects that glial modulators have on abuse-related behavioral effects, such as pleasure, withdrawal, and motivation and presents a brief overview of each of the major classes of addictive drugs on glia.
On Neuroimmunology and Brain Function: Experimental and Clinical Studies
TLDR
Genetic variants in immune-related genes were associated with neuropsychiatric traits and the volume of certain brain regions and the importance of the immune system for the development of psychiatric disorders is confirmed.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 146 REFERENCES
The role of the innate immune system in psychiatric disorders
TLDR
This review draws reference to biochemical, cellular and animal disease models, as well as clinical observations to elucidate the role of the innate immune system in psychiatric disorders and highlights future directions for studies, including the use of peripheral biomarkers relevant for developing new therapeutic approaches for treating psychiatric illnesses.
Inflamed moods: A review of the interactions between inflammation and mood disorders
TLDR
This synthetic review is to review the evidence for an association between inflammation and mood disorders, to discuss potential pathophysiologic mechanisms that may explain this association and to present novel therapeutic options currently being investigated that target the inflammatory-mood pathway.
Evidence for IL-1 receptor blockade as a therapeutic strategy for the treatment of depression.
TLDR
This review highlights the increasing interest in the relationship between IL-1 beta, neurogenesis, stress and depression, and discusses the potential ofIL-1Ra or other cytokine antagonists as new candidates for the treatment of depression.
Insights from interferon-α-related depression for the pathogenesis of depression associated with inflammation
TLDR
In view of the high incidence of depressive symptoms, IFN-α-related depression is an attractive model for studying links between neuronal plasticity, neurodegeneration and depression, and it is predicted that in the latter areas new targets for anti-depressant therapies could be identified, which may deepen the understanding of idiopathic major depression.
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
TLDR
Preliminary data from patients with inflammatory disorders, as well as medically healthy depressed patients, suggest that inhibiting proinflammatory cytokines or their signaling pathways may improve depressed mood and increase treatment response to conventional antidepressant medication.
A review of the relationship between proinflammatory cytokines and major depressive disorder.
TLDR
There is significant evidence that inflammatory processes influence the development and progression of MDD and future studies with larger arrays of cytokine profiles aided by neuroimaging may provide more sensitive and specific modes of diagnostics in determining MDD etiology and provide guidance in individual therapies.
Is unpredictable chronic mild stress (UCMS) a reliable model to study depression-induced neuroinflammation?
TLDR
Results indicate that microglial activation is significantly increased in the infralimbic, cingulate and medial orbital cortices, nucleus accumbens, caudate putamen, amygdala and hippocampus of the mouse brain as a function of UCMS, suggesting that UCMS could be a potentially reliable model to study depression-induced neuroinflammation.
Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder
TLDR
This review will discuss the most recent research surrounding novel compounds with primary mechanisms of action on the glutamatergic, cholinergic and opioid systems, and discusses novel device-based therapeutics, with a particular focus on transcranial magnetic stimulation.
Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes.
TLDR
This finding is important for improving treatment because it implies that therapeutics that reduce microglial activation should be promising for MDE and is consistent with the concept that neuroinflammation in specific regions may contribute to sickness behaviors that overlap with the symptoms of MDE.
Neuroinflammation and psychiatric illness
TLDR
The link between autoimmunity and neuropsychiatric disorders, and the human and experimental evidence supporting the pathogenic role of neuroinflammation in selected classical psychiatric disorders are reviewed.
...
1
2
3
4
5
...